TISSUE PROCUREMENT FACILITY SHARED RESOURCE The Tissue Procurement Facility (TPF) is the main conduit for access to protocol driven tissue-based research. As part of the 2019 strategic plan, this SR was expanded and reorganized to provide additional services and with a more robust pipeline for faculty conducting this type of clinical research. The expansion of this resource led to enhanced services including: ? More timely fresh tissue collection. TPF has developed a pipeline to collect fresh tissue for next-generation research focusing on single-cell and chip sequencing. The fresh tissue infrastructure requires significant collaboration between Surgical Pathology, Anatomic Pathology, TPF, and Clinical Protocol and Data Management (CPDM). For scRNA sequencing TPF has added an additional workflow to facilitate this methodology. ? Tissue dissociation. TPF is equipped for single-cell dissociation to process tissue to single-cell for investigators that do not have the technology to do so and/or are investigating more robust experiments. ? Ultrapure plasma processing. Ultra highspeed plasma purification for downstream cfDNA analysis. Ultrapure plasma will produce a significantly cleaner signal-to-noise ratio for investigators looking at cfDNA. TPFis led by an experienced faculty and staff. Dr. Calhoun is Director of Surgical Pathology and Anatomical Pathology at UNC and serves as Pathology Director. He works closely with the surgical liaison, co-leader HJ Kim to ensure responsible policies are in place for the procurement of research specimens following guidelines established by the UNC Hospitals. Amy Garratt serves as the Facility Director for the SR and its translational consenting and collection component. This is a well-managed resource with an operating budget of $1.0M. TPF requests $229,718 (21% of the total) for fiscal year 2020. LCCC members were more than 66% of the users in fiscal year 2019, virtually all other users were performing cancer research. The Facility procured, and distributed 46,091 specimens to support 154 different investigator-initiated studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-45
Application #
10089838
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Cai, Ling; Tsai, Yi-Hsuan; Wang, Ping et al. (2018) ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer. Mol Cell 72:341-354.e6
Moschos, Stergios J; Sullivan, Ryan J; Hwu, Wen-Jen et al. (2018) Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors. JCI Insight 3:
Brosnan, Evelyn M; Anders, Carey K (2018) Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies. Ann Transl Med 6:163
Valle, Carmina G; Queen, Tara L; Martin, Barbara A et al. (2018) Optimizing Tailored Communications for Health Risk Assessment: A Randomized Factorial Experiment of the Effects of Expectancy Priming, Autonomy Support, and Exemplification. J Med Internet Res 20:e63
Sun, Junjiang; Shao, Wenwei; Chen, Xiaojing et al. (2018) An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs. Mol Ther Methods Clin Dev 10:257-267
Wilczewski, Caralynn M; Hepperla, Austin J; Shimbo, Takashi et al. (2018) CHD4 and the NuRD complex directly control cardiac sarcomere formation. Proc Natl Acad Sci U S A 115:6727-6732
Waters, Andrew M; Der, Channing J (2018) KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer. Cold Spring Harb Perspect Med 8:
Gralinski, Lisa E; Sheahan, Timothy P; Morrison, Thomas E et al. (2018) Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. MBio 9:
Au, Kin Man; Tripathy, Ashutosh; Lin, Carolina Pe-I et al. (2018) Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma. ACS Nano 12:1544-1563
Mirlekar, Bhalchandra; Michaud, Daniel; Searcy, Ryan et al. (2018) IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer. Cancer Immunol Res 6:1014-1024

Showing the most recent 10 out of 1525 publications